Advertisement
Canada markets open in 1 hour 1 minute
  • S&P/TSX

    21,873.72
    -138.00 (-0.63%)
     
  • S&P 500

    5,071.63
    +1.08 (+0.02%)
     
  • DOW

    38,460.92
    -42.77 (-0.11%)
     
  • CAD/USD

    0.7309
    +0.0011 (+0.16%)
     
  • CRUDE OIL

    83.24
    +0.43 (+0.52%)
     
  • Bitcoin CAD

    87,537.63
    -3,643.34 (-4.00%)
     
  • CMC Crypto 200

    1,362.78
    -19.80 (-1.43%)
     
  • GOLD FUTURES

    2,338.40
    0.00 (0.00%)
     
  • RUSSELL 2000

    1,995.43
    -7.22 (-0.36%)
     
  • 10-Yr Bond

    4.6520
    +0.0540 (+1.17%)
     
  • NASDAQ futures

    17,468.25
    -196.25 (-1.11%)
     
  • VOLATILITY

    16.33
    +0.36 (+2.25%)
     
  • FTSE

    8,103.24
    +62.86 (+0.78%)
     
  • NIKKEI 225

    37,628.48
    -831.60 (-2.16%)
     
  • CAD/EUR

    0.6819
    0.0000 (0.00%)
     

Is AbbVie Stock a Top Pick for 2022?

Is AbbVie Stock a Top Pick for 2022?

Treasury yields are rising, and the Federal Reserve is expected to raise interest rates multiple times in 2022. In the case of AbbVie (NYSE: ABBV), look no further. AbbVie is a global prescription drug developer, manufacturer, and distributor that was spun off from parent company Abbott Labs back in 2013.